内镜与显微镜经蝶窦手术治疗垂体腺瘤:系统评价与Meta分析
该系统评价与Meta分析纳入23项研究(4项前瞻性、19项回顾性)共2272例垂体腺瘤患者,比较内镜与显微镜经蝶窦手术的疗效与安全性。内镜手术与更高的肿瘤全切率相关(OR 1.52,95%CI 1.11-2.08,P=0.009),并显著降低鼻中隔穿孔风险(OR 0.29,95%CI 0.11-0.78,P=0.014);脑脊液漏风险无显著差异,尿崩症风险降低22%但未达统计学显著。
要点
- 内镜经蝶窦手术的肿瘤全切率高于显微镜手术(OR 1.52,95%CI 1.11-2.08,P=0.009)。
- 内镜手术显著降低鼻中隔穿孔风险(OR 0.29,95%CI 0.11-0.78,P=0.014)。
- 脑脊液漏风险无显著差异,尿崩症风险降低22%但差异未达统计学显著。
核心结论
- 内镜经蝶窦手术与垂体腺瘤患者更高的肿瘤全切率和更低的鼻中隔穿孔发生率相关。
- 未来需要大规模前瞻性随机对照试验验证这些发现。
研究设计与样本
- 系统检索PubMed、Embase和Cochrane Library电子数据库以及主要会议论文集。
- 纳入评估内镜与显微镜方法治疗垂体腺瘤的回顾性或前瞻性设计研究。
- 最终分析纳入23项研究(4项前瞻性、19项回顾性),共2272例垂体腺瘤患者。
主要发现
- 内镜经蝶窦手术的肿瘤全切率高于显微镜经蝶窦手术(OR 1.52,95%CI 1.11-2.08,P=0.009)。
- 内镜经蝶窦手术与显微镜经蝶窦手术相比,脑脊液漏风险无显著影响。
- 内镜经蝶窦手术与显微镜经蝶窦手术相比,尿崩症风险降低22%,但差异未达统计学显著。
- 内镜经蝶窦手术显著降低鼻中隔穿孔风险(OR 0.29,95%CI 0.11-0.78,P=0.014)。
- 内镜经蝶窦手术与脑膜炎、鼻出血、血肿、垂体功能减退、甲状腺功能减退、皮质醇减低、总死亡率和复发风险无关。
关键数值与推荐
- 肿瘤全切:内镜 vs 显微镜 OR 1.52(95%CI 1.11-2.08,P=0.009)。
- 鼻中隔穿孔:内镜 vs 显微镜 OR 0.29(95%CI 0.11-0.78,P=0.014)。
- 尿崩症:内镜较显微镜风险降低22%,差异未达统计学显著。
- 脑脊液漏:内镜 vs 显微镜无显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来需要大规模前瞻性随机对照试验验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inconsistent findings have been reported regarding the efficacy and safety of endoscopic and microscopic transsphenoidal surgery for pituitary adenoma. This study aimed to assess the benefits and shortcomings of these surgical methods in patients with pituitary adenoma. METHODS: The electronic databases PubMed, Embase, and the Cochrane Library were systematically searched, as well as proceedings of major meetings. Eligible studies with a retrospective or prospective design that evaluated endoscopic versus microscopic methods in patients with pituitary adenoma were included. Primary outcomes included gross tumor removal, cerebrospinal fluid leak, diabetes insipidus, and other complications. RESULTS: Overall, 23 studies (4 prospective and 19 retrospective) assessing 2272 patients with pituitary adenoma were included in the final analysis. Endoscopic transsphenoidal surgery was associated with a higher incidence of gross tumor removal (odds ratio, 1.52; 95% confidence interval, 1.11-2.08; P = 0.009) than those with microscopic transsphenoidal surgery. In addition, endoscopic transsphenoidal surgery had no significant effect on the risk of cerebrospinal fluid leak, compared with microscopic transsphenoidal surgery. Furthermore, endoscopic transsphenoidal surgery was associated with a 22% reduction in risk of diabetes insipidus compared with microscopic transsphenoidal surgery, but the difference was not statistically significant. Endoscopic transsphenoidal surgery significantly reduced the risk of septal perforation (odds ratio, 0.29; 95% confidence interval, 0.11-0.78; P = 0.014) and was not associated with the risk of meningitis, epistaxis, hematoma, hypopituitarism, hypothyroidism, hypocortisolism, total mortality, and recurrence. CONCLUSIONS: Endoscopic transsphenoidal surgery is associated with higher gross tumor removal and lower incidence of septal perforation in patients with pituitary adenoma. Future large-scale prospective randomized controlled trials are needed to verify these findings.
引用
- Li A, Liu W, Cao P, et al. Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis. World Neurosurg. 2017. PMID: 28104521. doi:10.1016/j.wneu.2017.01.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。